Charles Schwab’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.8M Buy
695,352
+30,379
+5% +$578K ﹤0.01% 1986
2025
Q4
$10.5M Sell
664,973
-121,360
-15% -$2.17M ﹤0.01% 2119
2025
Q3
$15.2M Sell
786,333
-45,702
-5% -$893K ﹤0.01% 1894
2025
Q2
$17.2M Sell
832,035
-72,240
-8% -$1.5M ﹤0.01% 1753
2025
Q1
$22.1M Buy
904,275
+17,064
+2% +$438K ﹤0.01% 1588
2024
Q4
$21.2M Buy
887,211
+217,643
+33% +$6.91M ﹤0.01% 1670
2024
Q3
$28.4M Buy
669,568
+62,647
+10% +$3.28M 0.01% 1497
2024
Q2
$31.1M Buy
606,921
+83,601
+16% +$4.74M 0.01% 1386
2024
Q1
$32.7M Buy
523,320
+52,121
+11% +$3.55M 0.01% 1303
2023
Q4
$35.3M Buy
471,199
+18,803
+4% +$1.35M 0.01% 1227
2023
Q3
$38.5M Sell
452,396
-13,366
-3% -$1.27M 0.01% 1075
2023
Q2
$50.8M Sell
465,762
-57,361
-11% -$5.44M 0.01% 849
2023
Q1
$43.4M Buy
523,123
+11,013
+2% +$1.04M 0.01% 929
2022
Q4
$52.7M Buy
512,110
+32,201
+7% +$3.71M 0.02% 773
2022
Q3
$50.9M Buy
479,909
+1,123
+0.2% +$123K 0.02% 748
2022
Q2
$52.5M Sell
478,786
-7,104
-1% -$703K 0.02% 722
2022
Q1
$50.7M Buy
485,890
+2,289
+0.5% +$238K 0.02% 862
2021
Q4
$59.2M Buy
483,601
+12,223
+3% +$1.36M 0.02% 787
2021
Q3
$54.1M Buy
471,378
+48,499
+11% +$5.14M 0.02% 811
2021
Q2
$41M Buy
422,879
+5,462
+1% +$474K 0.01% 1013
2021
Q1
$30.8M Buy
417,417
+14,233
+4% +$1.06M 0.01% 1168
2020
Q4
$27.5M Buy
403,184
+8,099
+2% +$528K 0.01% 1175
2020
Q3
$23.1M Sell
395,085
-12,995
-3% -$684K 0.01% 1105
2020
Q2
$18.5M Buy
408,080
+12,854
+3% +$615K 0.01% 1241
2020
Q1
$22.8M Buy
395,226
+15,226
+4% +$1.04M 0.01% 927
2019
Q4
$23.7M Buy
380,000
+6,063
+2% +$359K 0.01% 1090
2019
Q3
$21.5M Buy
373,937
+21,710
+6% +$1.2M 0.01% 1092
2019
Q2
$19.1M Buy
352,227
+8,980
+3% +$456K 0.01% 1169
2019
Q1
$16.2M Buy
343,247
+26,263
+8% +$1.46M 0.01% 1244
2018
Q4
$18M Sell
316,984
-7,799
-2% -$437K 0.01% 1060
2018
Q3
$17.8M Buy
324,783
+14,800
+5% +$848K 0.01% 1222
2018
Q2
$18.2M Buy
309,983
+10,121
+3% +$604K 0.01% 1160
2018
Q1
$17M Buy
299,862
+24,779
+9% +$1.35M 0.01% 1117
2017
Q4
$13.5M Buy
275,083
+26,573
+11% +$1.21M 0.01% 1276
2017
Q3
$11.4M Buy
248,510
+27,031
+12% +$1.03M 0.01% 1331
2017
Q2
$8.65M Buy
221,479
+19,841
+10% +$761K 0.01% 1462
2017
Q1
$8.19M Buy
201,638
+10,742
+6% +$421K 0.01% 1449
2016
Q4
$7.34M Buy
190,896
+8,227
+5% +$281K 0.01% 1479
2016
Q3
$5.82M Buy
182,669
+13,776
+8% +$523K 0.01% 1543
2016
Q2
$6.75M Buy
168,893
+3,150
+2% +$117K 0.01% 1350
2016
Q1
$5.57M Buy
165,743
+3,629
+2% +$104K 0.01% 1451
2015
Q4
$5.03M Buy
162,114
+4,978
+3% +$147K 0.01% 1512
2015
Q3
$4.72M Buy
157,136
+18,441
+13% +$609K 0.01% 1513
2015
Q2
$4.38M Buy
138,695
+9,636
+7% +$252K 0.01% 1625
2015
Q1
$2.98M Buy
129,059
+5,568
+5% +$115K ﹤0.01% 1843
2014
Q4
$2.42M Sell
123,491
-20,437
-14% -$351K ﹤0.01% 1902
2014
Q3
$2.26M Sell
143,928
-68,870
-32% -$981K ﹤0.01% 1900
2014
Q2
$2.62M Sell
212,798
-9,745
-4% -$117K ﹤0.01% 1838
2014
Q1
$3.06M Buy
222,543
+3,120
+1% +$44.9K 0.01% 1699
2013
Q4
$3.23M Buy
219,423
+10,944
+5% +$148K 0.01% 1606
2013
Q3
$2.82M Buy
208,479
+2,632
+1% +$38.7K 0.01% 1623
2013
Q2
$3.11M Buy
+205,847
New +$2.89M 0.01% 1433

Other funds holding AMN

Charles Schwab's AMN Position: Q1 2026 in Review

Charles Schwab increased its AMN Healthcare (AMN) stake by 4.6% in Q1 2026, buying an estimated $578K and bringing the position to 695,352 shares worth $12.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1986.

Charles Schwab first reported a position in AMN in Q2 2013 and has held it in 52 quarters since. The position peaked at $59.2M in Q4 2021. 249 funds tracked by Wall St. Rank hold AMN as of Q1 2026.

  • Charles Schwab held 695,352 shares of AMN Healthcare worth $12.8M as of Q1 2026.
  • Charles Schwab bought 30,379 AMN Healthcare shares in Q1 2026, an estimated $578K.
  • AMN Healthcare made up ﹤0.01% of Charles Schwab's portfolio in Q1 2026, its #1986 holding.
  • Charles Schwab first reported a position in AMN Healthcare in Q2 2013 and has held it in 52 quarters since.
  • Charles Schwab's AMN Healthcare position peaked at $59.2M in Q4 2021.
  • 249 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2026.

Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.